Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today ...
Northern Ireland international Conor McMenamin makes a shock switch from Coleraine to Glentoran, which comes just two months after he signed for the Bannsiders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results